Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study

BACKGROUND: Multiple myeloma (MM) is associated with a high risk of thrombosis, particularly during the first months of treatment including immunomodulatory drugs (IMiDs). There is no consensus on prevention of thromboembolic risk in patients with de novo MM, and identification of patients requiring...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalayer, Emilie, Tardy‐Poncet, Brigitte, Karlin, Lionel, Chapelle, Céline, Montmartin, Aurélie, Piot, Michèle, Guyotat, Denis, Collet, Philippe, Lecompte, Thomas, Tardy, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332829/
https://www.ncbi.nlm.nih.gov/pubmed/30656281
http://dx.doi.org/10.1002/rth2.12161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332829/
https://www.ncbi.nlm.nih.gov/pubmed/30656281
http://dx.doi.org/10.1002/rth2.12161

Ejemplares similares